Earnings Labs
Revolution Medicines, Inc. logo

Revolution Medicines, Inc. (RVMD) Earnings Dates & History

NASDAQ·Healthcare·Biotechnology

$144.83

+9.92%

Mkt Cap $30.23B

EPS — Estimate vs Actual

Revenue — Estimate vs Actual

Quarterly History

Q1 2026

Feb 25, 2026

$3.68M-$1.58-$1.86-17.72%
Q4 2025

Nov 5, 2025

$1.69M-$1.42-$1.61-13.38%
Q3 2025

Aug 6, 2025

$27.53M-$0.94-$1.31-39.36%
Q2 2025

May 7, 2025

-$1.12-$1.13-0.89%
Q1 2025

Feb 26, 2025

$346.15K$261.59M+75471.86%-$1.01-$1.12-10.89%
Q4 2024

Nov 6, 2024

$346.15K-$0.89-$0.94-5.24%
Q3 2024

Aug 7, 2024

$750.00K-$0.77-$0.81-5.19%
Q2 2024

May 8, 2024

$1.37M-$0.75-$0.70+6.21%
Q1 2024

Feb 26, 2024

$1.09M$742.00K-31.93%-$0.86-$1.14-32.56%
Q4 2023

Nov 6, 2023

$670.00K-$1.01-$0.99+1.98%
Q3 2023

Aug 8, 2023

$1.56M$3.82M+145.13%-$0.83-$0.92-10.84%
Q2 2023

May 8, 2023

$2.94M$7.01M+138.57%-$0.84-$0.72+14.29%
Q1 2023

Feb 27, 2023

$7.80M$15.33M+96.47%-$0.84-$0.63+25.00%
Q4 2022

Nov 7, 2022

$6.34M$3.36M-47.04%-$0.87-$0.87+0.00%
Q3 2022

Aug 9, 2022

$7.02M$9.12M+29.89%-$0.87-$0.82+5.75%
Q2 2022

May 9, 2022

$8.58M$7.58M-11.71%-$0.82-$0.78+4.88%
Q1 2022

Feb 28, 2022

$8.99M$9.46M+5.23%-$0.65-$0.71-9.23%
Q4 2021

Nov 10, 2021

$923.42K$1.10M+19.23%-$0.62-$0.72-16.13%
Q3 2021

Aug 11, 2021

$8.70M$8.70M+0.00%-$0.55-$0.60-9.09%
Q2 2021

May 10, 2021

$9.94M$10.13M+1.96%-$0.52-$0.53-1.92%
Q1 2021

Mar 2, 2021

$8.75M-$0.37-$0.52-40.54%
Q4 2020

Nov 12, 2020

$11.69M$12.66M+8.33%-$0.39-$0.42-7.69%
Q3 2020

Aug 10, 2020

$7.85M$10.03M+27.78%-$0.34-$0.46-35.29%
Q2 2020

May 14, 2020

$10.39M$11.55M+11.11%-$0.33-$0.74-124.24%
Q1 2020

Mar 30, 2020

$12.09M-$0.41-$6.52-1490.24%
Q1 2020

Feb 13, 2020

$12.51M-$0.35
Q2 2019

Jun 30, 2019

$12.28M-$0.28
Q1 2019

Mar 31, 2019

$13.17M-$0.28
Q4 2018

Dec 31, 2018

$10.35M-$0.31